Collective Minds

Name: Collective Minds
Address: Svärdvägen 5, Danderyd, 18322, SE
Telephone: +46705218650

Hem
Sverige
Danderyd
Collective Minds

Imaging in Clinical Trials Solved

01/10/2026

Multi-site imaging trials rarely fail on the science. They fail on the workflow around it: protocols that vary by site, data formats that don't match, quality issues found only after database lock.

For CROs running imaging as a primary endpoint, that's not a minor inconvenience. It's rework, delay, and risk to the evidence itself.

Our white paper looks at where imaging-driven trials lose time today, and what a centralized, configurable platform changes: one place for data, workflows built around how sites actually work, and QC that happens while a scan can still be repeated.

Download it to see how: https://eu1.hubs.ly/H0yKHV-0

29/09/2026

Where does a clinical trial's imaging workflow actually lose time?

Not usually in one place. It's the handoffs: from image collection to QC, from QC to reader assignment, from central review to the endpoint data that goes into the analysis.

Each step can run well on its own and the study still slows down, because no one owns the moment a scan moves from one stage to the next. A QC flag sits unresolved because it's unclear who should act on it. A reader is assigned but has no visibility into what's already been checked. An endpoint depends on a review that finished days ago but hasn't been marked complete anywhere central.

Connecting image collection, QC, reader management, and central review into one visible pipeline is what turns those handoffs into a straight line instead of five separate systems to chase.

Talk to our imaging experts if you have an upcoming trial or an active trial where these handoffs are already causing friction.

25/09/2026

Here is a test for any imaging strategy.

Pick a patient at random. Could your team produce a complete acquisition-to-review timeline for them within minutes?

If that means cross-referencing several disconnected systems, the audit trail is not doing its job yet. It is one of nine components most imaging teams handle separately rather than as one strategy.

In our latest blog, we've written up all nine, with what each one actually requires. Link in the comments.

24/09/2026

🌍 Today is World Cancer Research Day

Every new cancer therapy has to prove itself in a clinical trial, and in oncology, much of that proof comes from imaging. Each scan helps show whether a treatment is working, and each one depends on people doing careful work, often across many sites and countries.

Supporting research has been part of who we are since the beginning. Working alongside trial teams, we see how much goes into every study: the patients who choose to take part, the site staff who collect and send each scan, the radiologists who read them, and the investigators and sponsors asking the questions worth answering.

To all of you: thank you. The work and progress you do today shapes the treatments available tomorrow.

22/09/2026

Who owns imaging when a sponsor brings in a centralized platform?

It's the question that quietly stalls a lot of these decisions, and it usually isn't about the technology. It's about whether adding a platform means adding a redundant vendor, or stepping on the CRO relationship already in place.

It doesn't have to be either. A CRO manages the trial. An imaging platform manages how imaging data moves, from site to central read to sponsor visibility. Built well, one supports the other instead of competing with it.

Less friction in the handoffs. Same oversight where it belongs.

18/09/2026

Imaging trials get planned around an assumption that is rarely tested: centralization means complexity, complexity means cost, and cost means time. Teams budget for all three and call it prudent.

Our Co-Founder and CEO, Anders Nordell, makes the counter-case in 19 seconds. The frictions are real. They are not inherent to centralized imaging.

Most of them sit in the handoffs around the imaging rather than in the imaging itself: how images leave the site, how long a query takes to resolve, how many hands a scan passes through before a reader opens it. Those are decisions made study by study, not fixed properties of a centralized model.

The distinction matters most at protocol stage. If speed, cost, and quality genuinely trade off against each other, the only lever left is scope. If most of the cost sits in workflow, the lever is design.

That is the premise Collective Minds is built on. If you are planning an imaging study, we are glad to talk through where the friction sits in your setup.

Less friction. Stronger evidence.

16/09/2026

Our team is back from the Europe.

Over the last two days, the conversations around imaging we've had, kept landing in the same place: frustration with how images are handled, and how much of the workflow is still manual.

Downloading, uploading, chasing sites by email, and tracking status somewhere outside the study systems.
Nobody called that a technology gap. They called it coordination work that quietly eats study time.

That's what Collective Minds is built for: a centralized imaging platform for clinical trials that keeps transfer and review status in one place.

Thanks to everyone who stopped by our booth. We look forward to continuing the conversations.

11/09/2026

Two days at Nordic Life Science Days in Stockholm, and the conversations we keep having are the same ones: imaging protocols written late, data that takes days to reach review, quality problems found after the scan window has closed.

Next week we are in Amsterdam, exhibiting at the COG CRO Summit Europe.

If you are planning imaging for an upcoming study, or you already know where the time goes on your current ones, come and find us. Those are the conversations we get most out of.

16 to 17 September. See you in Amsterdam!

10/09/2026

A scan comes off a scanner in Warsaw at nine in the morning. By the time the coordinating site in Boston opens, a qualified reader needs to have already looked at it. In a CNS trial, where the imaging read is often the endpoint itself, that handoff decides whether a patient is randomized on schedule and whether the data package still holds up a year later.

Our new guide covers the imaging biomarkers and modalities in use today, what changes when imaging runs across dozens of sites and several trial phases, and what a sound imaging strategy looks like for a CNS program. Read the full blog post using the link below:

https://eu1.hubs.ly/H0y9p5R0

09/09/2026

Day two at NLS Days.

Yesterday was busy in the best way. Plenty of people stopping by, and a lot of good conversations about imaging that slows trials down for reasons that have nothing to do with the science.

We are at Booth I:05 again today. Come and say hello, we would love to talk imaging.

Adress

Svärdvägen 5
Danderyd
18322

Telefon

+46705218650

Webbplats

https://www.collectiveminds.health/

Aviseringar

Bli först med att veta: vi skickar ett mejl när Collective Minds publicerar nyheter och kampanjer. Din e-postadress används inte till något annat, och du kan avsluta prenumerationen när som helst.

Kontakta Affären

Skicka ett meddelande till Collective Minds:

Dela

Kategori

Mjukvaruföretag